921
Views
0
CrossRef citations to date
0
Altmetric
Polycystic ovary syndrome

Could sestrin protein in serum be a new marker of oxidative stress in patients with polycystic ovary syndrome?

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1109-1113 | Received 02 May 2022, Accepted 09 Dec 2022, Published online: 04 Jan 2023

References

  • Fauser BC, Tarlatzis BC, Rebar RW, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS consensus workshop group. Fertil Steril. 2012;97(1):28–38. e25.
  • Wekker V, Van Dammen L, Koning A, et al. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2020;26(6):942–960.
  • Zeng X, Xie Y-J, Liu Y-T, et al. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020;502:214–221.
  • Willis DS, Watson H, Mason HD, et al. Premature response to luteinizing hormone of granulosa cells from an ovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab. 1998;83(11):3984–3991.
  • Franks S, Mason H, White D, et al. Mechanisms of anovulation in polycystic ovary syndrome. Steroids. 1997;11(62):728.
  • Victor VM, Rocha M, Banuls C, et al. Induction of oxidative stress and human leukocyte/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance. J Clin Endocrinol Metab. 2011;96(10):3115–3122.
  • Al-Gubory KH, Fowler PA, Garrel C. The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int J Biochem Cell Biol. 2010;42(10):1634–1650.
  • Sun Y, Li S, Liu H, et al. Oxidative stress promotes hyperandrogenism by reducing sex hormone-binding globulin in polycystic ovary syndrome. Fertil Steril. 2021;116(6):1641–1650.
  • Murri M, Luque-Ramírez M, Insenser M, et al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update. 2013;19(3):268–288.
  • Lee JH, Budanov AV, Karin M. Sestrins orchestrate cellular metabolism to attenuate aging. Cell Metab. 2013;18(6):792–801.
  • Li H, Liu S, Yuan H, et al. Sestrin 2 induces autophagy and attenuates insulin resistance by regulating AMPK signaling in C2C12 myotubes. Exp Cell Res. 2017;354(1):18–24.
  • Fauser B. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility. 2004;81(1):19–25.
  • Zegers-Hochschild F, Adamson GD, Dyer S, et al. The international glossary on infertility and fertility care, 2017. Hum Reprod. 2017;32(9):1786–1801.
  • Ramezani Tehrani F, Rashidi H, Bahri Khomami M, et al. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in southwest of Iran. Reprod Biol Endocrinol. 2014;12(1):89–86.
  • Budanov AV. Stress-responsive sestrins link p53 with redox regulation and mammalian target of rapamycin signaling. Antioxid Redox Signal. 2011;15(6):1679–1690.
  • Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005;3(1):1–21.
  • Sabuncu T, Vural H, Harma M, et al. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem. 2001;34(5):407–413.
  • Chen S-D, Yang J-L, Lin T-K, et al. Emerging roles of sestrins in neurodegenerative diseases: counteracting oxidative stress and beyond. JCM. 2019;8(7):1001.
  • Kim MG, Yang JH, Kim KM, et al. Regulation of toll-like receptor-mediated Sestrin2 induction by AP-1, Nrf2, and the ubiquitin-proteasome system in macrophages. Toxicol Sci. 2015;144(2):425–435.
  • Yang JH, Kim KM, Kim MG, et al. Role of sestrin2 in the regulation of proinflammatory signaling in macrophages. Free Radic Biol Med. 2015;78:156–167.
  • Deba Z, Jambale TA, Swamy PG, et al. Study of levels of malondialdehyde, super oxide dismutase and hs-CRP in serum of non-obese patients with polycystic ovarian syndrome. Int J Clin Biochem. 2017;4:191–194.
  • Papalou O, M, Victor V, Diamanti-Kandarakis E. Oxidative stress in polycystic ovary syndrome. Curr Pharm Des. 2016;22(18):2709–2722.
  • Zuo T, Zhu M, Xu W. Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxid Med Cell Longev. 2016;2016:8589318.
  • Rodríguez‐Moran M, Guerrero‐Romero F, Aradillas‐García C, et al. Obesity and family history of diabetes as risk factors of impaired fasting glucose: implications for the early detection of prediabetes. Pediatr Diabetes. 2010;11(5):331–336.
  • Azziz R, Kashar-Miller M. Family history as a risk factor for the polycystic ovary syndrome. J Pediatric Endocrinol Metabol JPEM. 2000;13:1303–1306.
  • Liu Y, Li M, Du X, et al. Sestrin 2, a potential star of antioxidant stress in cardiovascular diseases. Free Radic Biol Med. 2021;163:56–68.
  • Chen Y, Huang T, Yu Z, et al. The functions and roles of sestrins in regulating human diseases. Cell Mol Biol Lett. 2022;27(1):2–24.
  • Fay J. The crucial role of sestrins in oxidative stress response and disease: an analysis of phosphorylation mutation S110A in hSesn2. 2022.
  • Fatima MT, Hasan M, Abdelsalam SS, et al. Sestrin2 suppression aggravates oxidative stress and apoptosis in endothelial cells subjected to pharmacologically induced endoplasmic reticulum stress. Eur J Pharmacol. 2021;907:174247.
  • Kishimoto Y, Kondo K, Momiyama Y. The protective role of Sestrin2 in atherosclerotic and cardiac diseases. IJMS. 2021;22(3):1200.